Biotech
> La Jolla Pharmaceutical appointed Dennis Mulroy as its chief financial officer. Release
> Acceleron brought on Dr. Francois Nader as the chairman of its board of directors. Release
> Shontelle Dodson joined Astellas Pharma as the leader of medical excellence. Release
> Raze Therapeutics appointed Mark Manfredi as its chief scientific officer. Release
> Dr. Roberto Guerciolini will act as senior vice president and head of early development at WaVe Life Sciences. Release
> EHE International brought on Dr. Romeo Papica as a partner. Release
> PlasmaTech appointed Dr. Robert Sandhaus to its scientific advisory board. Release
> AnaptysBio brought in former Pfizer ($PFE) head of cancer biology Gerrit Los to lead its translational biology team. Release
> Caris Life Sciences names David Spetzler as chief scientific officer. Release
> aTyr Pharma appoints Marcy Graham as vice president, investor relations and corporate communications. Release
> Avidity NanoMedicines appoints Andrew Geall as vice president of formulations and chemistry. Release
> Aegerion ($AEGR) adds Dr. Jorge Plutzky to its board of directors. Release
> Aridis Pharmaceuticals names Craig Gibbs to its board of directors. Release
> Osiris Therapeutics appoints Alla Danilkovitch as chief scientific officer. Release
> Horizon Pharma ($HZNP) names Geoffrey Curtis as group vice president, corporate communications. Release
> Revolution Medicines recruits Elizabeth McKee Anderson, formerly of Janssen Pharmaceuticals, to its board of directors. Release
> Flamel Technologies announced that Steve Lisi, senior vice president of business and corporate development, has left the company. Release
> Relmada Therapeutics names Lisa Nolan as senior vice president of business development. Release
> Endocyte ($ECYT) appoints Dr. P. David Mozley as vice president of imaging. Release
> PTC Therapeutics ($PTCT) names Eric Pauwels as senior vice president and general manager of commercial operations, Americas. Release
> Domainex appoints Barry Knight as chief financial officer and company secretary and Thomas Mander as chief operating officer. Release
> Allergen Research Corporation appoints Mary Rozenman as senior vice president of corporate and commercial development and Mike Holfinger as vice president of manufacturing. Release
> BioRestorative Therapies adds Charles Ryan to its board of directors. Release
> BioSig Technologies adds Dr. Jerome Zeldis to its board of directors. Release
> Regeneron ($REGN) appoints Brian Zambrowicz as vice president of functional genomics and chief of VelociGene operations. Release (PDF)
Med tech
> DJO Global named Jeanine Kestler as executive vice president and chief human resources officer, effective April 6. Release
> SteadyMed ($STDY) appoints David Nassif as executive vice president and chief financial officer. Release
Vaccines
> Tom Varvaro joined MabVax's board of directors. Release
|